140 likes | 154 Views
Understand the key documents, tools, and guidelines for writing procurement and supply management plans. Learn about drug management elements and proposal writing strategies using GFATM funds to overcome system gaps. Explore policies, regulations, and indicators for monitoring and evaluation in procurement and supply management.
E N D
Thomas Moore, Management Sciences for Health Procurement and Supply Management (PSM) Workshop: Understanding basic drug management elements for proposal writingBangkok, ThailandJuly 25-30, 2005
Introduction (1) • Key GFATM documents • Guidelines for Proposals • Proposal Form • M & E Toolkit • PSM Assessment Tool • Workshop handouts • “Description of Interventions” • “Pharmaceutical Management Guide for Procurement and Supply Management plan for GFATM proposals” • “Tools for forecasting drug needs” • This Power Point presentation
Introduction (2) • Describe your drug management system • Use the six basic elements in the “framework” slide • Describe any gaps within each of the six elements in your drug management system Examples: (1) no drug policy to govern supply and use; (2) no mechanism for good forecasting • Describe how you will use the GFATM funds to overcome the gaps Note: see other suggestions on your handout “Pharmaceutical Management Guide for Writing Procurement and Supply Management plans for GFATM proposals
Introduction (3) • In GFATM budget proposal must include a breakdown of: • Functional areas for: • Monitoring and Evaluation • Procurement and Supply Management • Technical Assistance • Service delivery areas • Partner allocation
Selection Management Procurement Use Support Distribution Policy and Legal Framework Framework: Pharmaceutical Management Cycle
Policy, Regulations, and Laws (1) • Develop or update government TB policy • Develop policy for health care system reforms • Decentralized vs. Centralized • Vertical vs. integrated • Role of Private sector healthcare providers
Policy, Regulations, and Laws (2) • Update drug policy for good procurement and supply management • Reinforce drug regulation capacity • National Drug Authority • Update Essential drugs list • Require use of generic vs. brand names • Develop regulations re: Importing, distribution, sales • Promote good manufacturing practices (GMPs)
Suggestions for PSM plan-Policy (1) • Personnel needs • Regulatory activities • Monitoring, inspection, surveillance, enforcement • Training • Infrastructure • Office space • Computers, software, equipment • Access to Quality Control laboratory facilities • Vehicles for distribution, inspection, enforcement
Suggestions for PSM plan-Policy (2) • Update drug laws and regulations • Publish standard treatment guidelines • Update National Essential Medicines List • Disseminate information to all organizational levels • Require good procurement practices • Require drug registration to promote public safety • Require GMP compliance by local drug manufacturers
Indicators for M & E - Policy • Average time, in days, required to clear shipments of TB drugs from the port of entry* • Average number of days to register TB drugs • Percentage of TB treatment facilities that have the latest official manual of TB treatment guidelines • When post-marketing surveillance exists • Product quality complaints • Adverse drug reaction reporting • Inspection of wholesalers and retail pharmacies • Testing/sampling
Procurement - quantification/forecasting • Needed for: • Planning, budgeting, and ordering • Critical issues: • Must first have good selection of drugs • Decide who will quantify - centralized vs. decentralized activity • Tools to use - manual vs. computerized • Knowledge of lead times, stock-outs, safety stock, growth, losses • Reconcile quantities needed with budget
Options for Quantification • Morbidity based: Base estimates on expected number of cases • Consumption based: Estimates based on past consumption • Adjusted-consumption based: Estimates based on data from another region or health service
Comparison of Quantification Methods Consumption versus Morbidity • Consumption – need good inventory records • Morbidity- need patient attendance data • Both methods – need data on existing stocks, lead times, costs QUAN8
Indicators for M & E – drug quantification • Average percentage of a set of tracer TB commodities available in TB facilities and medical stores • Average percentage of time out of stock for a set of TB tracer commodities in TB facilities • Presence of 6 months buffer stock at national level and 3 months stock at district level